Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
Clinical trial NCT03108352 · COMPLETED
Trial details
- NCT number
- NCT03108352
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-13
- Primary completion
- 2020-04-13
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.